Evidence map›Paper›PMID 21085684›Full record

ArticlePloS one2010

Phospholipase D family member 4, a transmembrane glycoprotein with no phospholipase D activity, expression in spleen and early postnatal microglia.

Fumio Yoshikawa, Yoshiko Banno, Yoshinori Otani, Yoshihide Yamaguchi, Yuko Nagakura-Takagi, Noriyuki Morita, Yumi Sato, Chihiro Saruta, Hirozumi Nishibe, Tetsushi Sadakata and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Human marginal zone B cell development from early T2 progenitors.The Journal of experimental medicine · 2021
    Article
  12. Review
  13. Phospholipase Signaling in Breast Cancer.Advances in experimental medicine and biology · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Targeting Phospholipase D4 Attenuates Kidney Fibrosis.Journal of the American Society of Nephrology : JASN · 2017
    Article
  20. rs2841277 (Oncotarget · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Fumio YoshikawaLaboratory for Molecular Neurogenesis, RIKEN Brain Science Institute, Wako, Saitama, Japan.
Yoshiko Banno
Yoshinori Otani
Yoshihide Yamaguchi
Yuko Nagakura-Takagi
Noriyuki Morita
Yumi Sato
Chihiro Saruta
Hirozumi Nishibe
Tetsushi Sadakata
Yo Shinoda
Kanehiro Hayashi
Yuriko Mishima
Hiroko Baba
Teiichi Furuichi
RIKEN Center for Brain Science · JPJapan Science and Technology Agency · JPTokyo University of Pharmacy and Life Sciences · JPGifu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhospholipase D (PLD) catalyzes conversion of phosphatidylcholine into choline and phosphatidic acid, leading to a variety of intracellular signal transduction events. Two classical PLDs, PLD1 and PLD2, contain phosphatidylinositide-binding PX and PH domains and two conserved His-x-Lys-(x)(4)-Asp (HKD) motifs, which are critical for PLD activity. PLD4 officially belongs to the PLD family, because it possesses two HKD motifs. However, it lacks PX and PH domains and has a putative transmembrane domain instead. Nevertheless, little is known regarding expression, structure, and function of PLD4. METHODOLOGY/PRINCIPAL

findingsPLD4 was analyzed in terms of expression, structure, and function. Expression was analyzed in developing mouse brains and non-neuronal tissues using microarray, in situ hybridization, immunohistochemistry, and immunocytochemistry. Structure was evaluated using bioinformatics analysis of protein domains, biochemical analyses of transmembrane property, and enzymatic deglycosylation. PLD activity was examined by choline release and transphosphatidylation assays. Results demonstrated low to modest, but characteristic, PLD4 mRNA expression in a subset of cells preferentially localized around white matter regions, including the corpus callosum and cerebellar white matter, during the first postnatal week. These PLD4 mRNA-expressing cells were identified as Iba1-positive microglia. In non-neuronal tissues, PLD4 mRNA expression was widespread, but predominantly distributed in the spleen. Intense PLD4 expression was detected around the marginal zone of the splenic red pulp, and splenic PLD4 protein recovered from subcellular membrane fractions was highly N-glycosylated. PLD4 was heterologously expressed in cell lines and localized in the endoplasmic reticulum and Golgi apparatus. Moreover, heterologously expressed PLD4 proteins did not exhibit PLD enzymatic activity. CONCLUSIONS/SIGNIFICANCE: Results showed that PLD4 is a non-PLD, HKD motif-carrying, transmembrane glycoprotein localized in the endoplasmic reticulum and Golgi apparatus. The spatiotemporally restricted expression patterns suggested that PLD4 might play a role in common function(s) among microglia during early postnatal brain development and splenic marginal zone cells.

Indexed as

Amino Acid SequenceAnimalsBrainCell LineChlorocebus aethiopsCOS CellsEndoplasmic ReticulumExonucleasesGene Expression Regulation, EnzymologicGolgi ApparatusHEK293 CellsHeLa CellsHumansImmunohistochemistryIn Situ HybridizationMembrane GlycoproteinsExonucleasesMembrane GlycoproteinsPhospholipase DPLD4 protein, mouse

Identifiers

PMID21085684
PMCPMC2978679
OpenAlexW2062559584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.